Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1989;74:185-189
© 1989 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CAIN, J. M.
Right arrow Articles by FIGGE, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CAIN, J. M.
Right arrow Articles by FIGGE, D. C.

The Morbidity and Benefits of Concurrent Gracilis Myocutaneous Graft With Pelvic Exenteration

JOANNA M. CAIN, ANGELA DIAMOND, MD, HISHAM K. TAMIMI, MD, BENJAMIN E. GREER, MD and DAVID C. FIGGE, MD

From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington

Abstract

This study was undertaken to evaluate the morbidity and potential benefits of concurrent gracilis myocutaneous graft with exenteration. All patients undergoing exenteration from 1962-1986 were reviewed, of whom 24 had concurrent grafts. The mean operative time, blood loss, and hospital stay were not different in patients with versus without grafts. The rate of fistula formation in the hospital was less in the graft group (P=.004) but was not different when compared with contemporary patients only. The total infection rate (wound and pelvic) was decreased in the graft group (P=.04) when graft infections were excluded. The major problem with the graft was significant necrosis of the flap(s) in nine of the 24 patients. There were no life-threatening complications attributed to concurrent placement of gracilis myocutaneous flaps. Experience with the technique is improving the cosmetic and functional outcome of the neovagina formed with the graft. Patients most likely to benefit from this procedure include those requiring immediate reconstruction or those with potentially poor healing due to high-dose pelvic radiation, including intraoperative radiation.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
A. K. Sood, B. C. Cooper, J. I. Sorosky, P. T. Ramirez, and C. Levenback
Novel Modification of the Vertical Rectus Abdominis Myocutaneous Flap for Neovagina Creation
Obstet. Gynecol., March 1, 2005; 105(3): 514 - 518.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Obstetricians and Gynecologists.